Prexton Therapeutics
Prexton Therapeutics has the mission to develop innovative drugs to improve the quality of life. Prexton Therapeutics is a Swiss-based biopharmaceutical company, founded in 2012 by Francois Conquet and MS Ventures as part of the Merck Serono Entrepreneur Partnership Program, a facility to support the creation of spin-offs from Merck Serono. Prexton Therapeutics applies a new scientific approach...
Prevention
Technology
2012
Founded
1-10
Employees
P3 Medicine
Industry
Visual (Placeholder)
Profile Information
Name
Prexton Therapeutics
Industry
P3 Medicine
Technology
Prevention
Location
Plan-les-ouates, Geneve, Switzerland
Founded
2012
Employees
1-10
Category
Company
Contact Information
Email
info@prextontherapeutics.com
Phone
N/A
Address
N/A